Press enter to see results or esc to cancel.

Digital Health Exit Candidates

The list of potential digital health exit candidates is based on a number of criteria such as the amount of money raised, competitors that went public, notable partnerships and clients, growth figures, and more. Included are both SPAC candidates as well as those that could have their exit through a traditional IPO or in an M&A deal.

Flo Health

🏦 Potential exit path: SPAC, IPO, M&A
Headquarters: London, United Kingdom
Category: Women's Health
Funding Amount: $75.5M
πŸ’Έ Last round (Series B) worth $50 was raised on September 9, 2021. at valuation of $800M
Select investors: Target Global, VNV Global, Elysium Venture Capital, Babylon Health, Lyft, Delivery Hero, Founders Fund, Flint Capital, Mangrove Capital Partners
Flo is one of the most popular women's health apps globally. It uses Data Science and AI to support women during their entire reproductive lives and provides curated cycle and ovulation tracking, personalized health insights, expert tips, and a private community for women to share their questions and concerns. The app prioritizes safety and keeps a sharp focus on being the most trusted digital source for women's health information. Flo is a part of Palta, a health & well-being technology company led by entrepreneurs on a mission to create a global positive impact. more »

Elemy

🏦 Potential exit path: SPAC, IPO
Headquarters: San Francisco, California, United States
Category: Pediatric Care
Funding Amount: $323M πŸ¦„
πŸ’Έ Last round (Series B) worth $219M was raised on October 6, 2021. at valuation of $1.15B
Select investors: SoftBank Vision Fund, General Catalyst, Female Founders Fund, 8VC, Goodwater Capital, Sound Ventures, SignalFire, e.ventures, Amity Ventures
Formerly known as Sprout Therapy, Elemy is a B2B2C platform for in-home pediatric behavioral care, including pediatric autism, ADHD, anxiety and more. The company works with Medicaid programs and insurance companies, leveraging technology to deliver a better experience to families, providers, and healthcare payors. Said technology is based around a model of care that Elemy describes as "integrated, evidence-based, and personalized." more »

Wheel

🏦 Potential exit path: SPAC, IPO
Headquarters: Austin, Texas, United States
Category: Telehealth
Funding Amount: $216M
πŸ’Έ Last round (Series C) worth $150M was raised on January 19, 2022.
Select investors: Lightspeed Venture Partners, Tiger Global Management, JPMorgan Chase, Coatue Management, Salesforce Ventures, CRV, Tusk Venture Partners, Silverton Partners
Formerly known as Enzyme Health, Wheel is a healthcare technology company powering virtual care, with its technology enabling companies and clinicians need to deliver care virtually. The company's platform makes it simple for companies to build virtual care services under their brand by providing the infrastructure and clinicians. For clinicians, Wheel offers one place to manage their entire virtual care practice, including training and work opportunities. Its clients include digital health companies, clinical lab networks, retailers, and tech companies. more »

Verana Health

🏦 Potential exit path: SPAC, IPO
Headquarters: San Francisco, California, United States
Category: Analytics
Funding Amount: $288.8M
πŸ’Έ Last round (Series E) worth $150M was raised on January 14, 2022.
Select investors: JJDC, Novo Growth, GV, Merck Global Health Innovation Fund, Casdin Capital, Breyer Capital, Define Ventures, Biomatics Capital
Verana Health is committed to delivering quality drug lifecycle and medical practice insights from an exclusive real-world data network. The company is entrusted by a few specialty medical societies to manage data from more than 20,000 healthcare providers and 70 electronic health record systems. Its healthcare data ecosystem is powered by VeraQ, a population health data engine that securely powers a data integrity feedback loop of nearly a half-billion, point-of-care health encounters. By applying advanced analytics to fit-for-purpose, quality data sets (Qdata), Verana Health helps life sciences collaborators generate real-world evidence, advance business insights, and accelerate medical innovations that promote quality of care and quality of life. more »

Alto Pharmacy

🏦 Potential exit path: SPAC, IPO, M&A
Headquarters: San Francisco, California, United States
Category: Digital Pharmacy
Funding Amount: $612.4M πŸ¦„
πŸ’Έ Last round (Series E) worth $200M was raised on January 27, 2022.
Select investors: SoftBank Vision Fund, Greenoaks Capital, Zola Global, Olive Tree Capital, Jackson Square Ventures, Nimble Ventures, Esas Ventures
Alto is on a mission to transform a $500 billion industry by reinventing what a pharmacy can do. It is a digital pharmacy that provides customers with access to medication by scheduling delivery to their home or office the same day, seven days a week. People can also see medication price comparisons, manage their medications, and connect directly with a pharmacist to help them stay on track. Providers also use Alto's technology to streamline administrative workflows, like benefits investigation and insurance authorizations. more »
Disclaimer: The content on this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances.